IPO registrations (S-1, F-1) · Registrants
CureVac N.V.
- SEC CIK
- 1809122 · filings on EDGAR ↗
- Former names
- CureVac B.V. (2020–2020)
- Registration
- Form F-1, first filed 2020-07-24, last 2021-01-25; 2 initial registrations, 3 amendments
- Outcome
- Final prospectus filed 2020-08-14; declared effective 2020-08-13
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- P7
- Business address
- FRIEDRICH-MIESCHER-STRASSE 15, Tubingen 72076
- EDGAR entity type
- other
Offering terms
- Proposed price range
- $14.00–$16.00 per share (F-1/A filed 2020-08-10)
- Final price
- $16.00 per share, within the range (424B4 filed 2020-08-14, an initial public offering)
- Shares sold
- 13,333,333
- Gross proceeds
- $213,333,328 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol CVAC
- Lead underwriters
- BofA Securities; Jefferies; Credit Suisse
- Syndicate
- Kempen & Co
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
Filings 9
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2020-07-24 | F-1 | F-1 (foreign registration) | CureVac B.V. | 0001104659-20-086354 ↗ |
| 2020-07-31 | F-1/A | F-1/A (amendment) | CureVac B.V. | 0001104659-20-089179 ↗ |
| 2020-08-07 | F-1/A | F-1/A (amendment) | CureVac B.V. | 0001104659-20-091817 ↗ |
| 2020-08-10 | F-1/A | F-1/A (amendment) | CureVac B.V. | 0001104659-20-092289 ↗ |
| 2020-08-13 | EFFECT | EFFECT (declared effective) | CureVac B.V. | 9999999995-20-002135 ↗ |
| 2020-08-14 | 424B4 | 424B4 (final prospectus) | CureVac N.V. | 0001104659-20-095636 ↗ |
| 2021-01-25 | F-1 | F-1 (foreign registration) | CureVac N.V. | 0001104659-21-007168 ↗ |
| 2021-01-27 | EFFECT | EFFECT (declared effective) | CureVac N.V. | 9999999995-21-000314 ↗ |
| 2021-01-29 | 424B4 | 424B4 (final prospectus) | CureVac N.V. | 0001104659-21-009416 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2020-08-10 | F-1/A | registration statement | $14.00–$16.00 | $15.00 | 13,333,333 | $199,999,995 | Nasdaq CVAC | 4 | primary document; range, price sentence, shares headline, proceeds computed, cover names 4 | document ↗ |
| 2020-08-14 | 424B4 | final prospectus | $16.00 | 13,333,333 | $213,333,328 | Nasdaq CVAC | 4 | primary document; price sentence, shares headline, proceeds table, cover names 4 | document ↗ |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Others with the same interests
SIC industry Pharmaceutical Preparations:
- MorphoSys AG 2M
- Affimed N.V. 2M
- InflaRx N.V. 2M
- Biofrontera AG 2M
- CURAXIS PHARMACEUTICAL Corp 2Q
- ONCOGENEX TECHNOLOGIES INC A1
- Aspreva Pharmaceuticals CORP A1
- Lexaria Bioscience Corp. A1
- Zymeworks BC Inc. A1
- BetterLife Pharma Inc. A1
Interests: Pharmaceutical Preparations · Health